These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1372879)

  • 1. Histochemistry of the prostate.
    Allsbrook WC; Simms WW
    Hum Pathol; 1992 Mar; 23(3):297-305. PubMed ID: 1372879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histochemistry and quantitative microscopy of prostate cancer.
    Bennett BD
    Prog Clin Biol Res; 1987; 239():711-58. PubMed ID: 2443917
    [No Abstract]   [Full Text] [Related]  

  • 3. New developments in biological markers in prostate cancer.
    Pontes JE
    Recent Results Cancer Res; 1990; 118():186-9. PubMed ID: 1700455
    [No Abstract]   [Full Text] [Related]  

  • 4. Signet ring cell carcinoma of prostate. Immunohistochemical and ultrastructural study of a case.
    Hejka AG; England DM
    Urology; 1989 Sep; 34(3):155-8. PubMed ID: 2476883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uses and limitations of prostate-specific antigen in the laboratory diagnosis of prostate cancer.
    Wells DJ; Bennett BD; Gardner WA
    South Med J; 1988 Feb; 81(2):218-20. PubMed ID: 2448884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucins in prostatic intra-epithelial neoplasia and prostatic carcinoma.
    Sentinelli S
    Histopathology; 1993 Mar; 22(3):271-4. PubMed ID: 7684356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of tumor cells in bone marrow of patients with prostatic carcinoma by immunocytochemical techniques.
    Mansi JL; Berger U; Wilson P; Shearer R; Coombes RC
    J Urol; 1988 Mar; 139(3):545-8. PubMed ID: 2449548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The clinical evaluation of prostatic specific antigen in prostatic cancer].
    Hiromoto Y; Hiramori M; Higaki Y; Imammura K
    Nihon Hinyokika Gakkai Zasshi; 1988 Apr; 79(4):606-12. PubMed ID: 2465428
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunohistochemical detection of prostate carcinoma].
    Ma WX; Li W
    Zhonghua Bing Li Xue Za Zhi; 1989 Mar; 18(1):37-9. PubMed ID: 2476252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deoxyribonucleic acid ploidy and the direct assay of prostatic acid phosphatase and prostate specific antigen in fine needle aspiration biopsies as diagnostic methods in prostatic carcinoma.
    Stege R; Lundh B; Tribukait B; Pousette A; Carlström K; Hasenson M
    J Urol; 1990 Aug; 144(2 Pt 1):299-302. PubMed ID: 1695689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epididymal metastasis from prostatic adenocarcinoma mimicking adenomatoid tumor.
    Rizk CC; Scholes J; Chen SK; Ward J; Romas NA
    Urology; 1990 Dec; 36(6):526-30. PubMed ID: 1701066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of prostate-specific acid phosphatase and prostate-specific antigen immunocytochemistry with survival in prostate carcinoma.
    Hammond ME; Sause WT; Martz KL; Pilepich MV; Asbell SO; Rubin P; Myers RP; Farrow GM
    Cancer; 1989 Feb; 63(3):461-6. PubMed ID: 2463874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relation of prostatic acid phosphatase and prostate specific antigen with tumour grade in prostatic adenocarcinoma: an immunohistochemical study.
    Ersev A; Ersev D; Turkeri L; Ilker Y; Simsek F; Kullu S; Akdas A
    Prog Clin Biol Res; 1990; 357():129-34. PubMed ID: 1699237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Simultaneous determination of prostatic acid phosphatase and prostate-specific antigen in carcinoma of the prostate. 2 years' experience].
    Mannini D; Aiello E; Maver P; Corrado G; Vecchi F; Bellanova B
    Minerva Urol Nefrol; 1987; 39(4):335-41. PubMed ID: 2453928
    [No Abstract]   [Full Text] [Related]  

  • 15. Characterization of a prostate carcinoma mucin-like antigen (PMA).
    Beckett ML; Wright GL
    Int J Cancer; 1995 Sep; 62(6):703-10. PubMed ID: 7558418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical aspects of diagnosis and monitoring of prostate cancer.
    Mahler C
    Horm Res; 1989; 32 Suppl 1():55-7; discussion 58. PubMed ID: 2482245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Schistosomiasis, metaplasia and squamous cell carcinoma of the prostate: histogenesis of the squamous cancer cells determined by localization of specific markers.
    Al Adnani MS
    Neoplasma; 1985; 32(5):613-22. PubMed ID: 2415839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical markers for prostatic carcinoma.
    Fair WR
    Prog Clin Biol Res; 1987; 239():659-80. PubMed ID: 2443916
    [No Abstract]   [Full Text] [Related]  

  • 19. Crescentic glomerulonephritis associated with prostatic carcinoma: evidence of immune-mediated glomerular injury.
    Haskell LP; Fusco MJ; Wadler S; Sablay LB; Mennemeyer RP
    Am J Med; 1990 Feb; 88(2):189-92. PubMed ID: 1689105
    [No Abstract]   [Full Text] [Related]  

  • 20. Prostatic acid phosphatase, beta-glucuronidase and prostate specific antigen assays in fine needle aspirates from benign and malignant prostates.
    Erickson DR; Hlavinka TC; Rockwood AP; Metter JD; Novicki DE; Fried MG
    J Urol; 1991 Nov; 146(5):1402-7. PubMed ID: 1719247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.